Buy Simplex Infra, target Rs 600: Motilal Oswal

Published on Mon, Nov 09, 2009 at 16:31 |  Source : Moneycontrol.com

Updated at Mon, Nov 09, 2009 at 16:38  

3236 Investors following Simplex Infra. Share this News with them.
0
0
Share on Tumblr
Buy Simplex Infra, target Rs 600: Motilal Oswal

ALSO READ

Motilal Oswal has maintained a buy rating on Simplex Infra , with target of Rs 600, in its report dated November 4, 2009. The stock closed at Rs 518.30 on November 9, 2009.

"Order book for Simplex stands at Rs 105 billion (down 1.5%YoY, up 5%QoQ), and is largely stagnant for past 6 quarters. Power segment contributed 61% of order intake in 1QFY10 and ~47% in 2QFY10. While the order intake during 2QFY10 has been moderate, bids submitted pipeline stands at Rs 390 billion (up 30% YoY, up 20% QoQ) indicating improved environment as compared to past 2-3 quarters. Management guidance lowered (for revenues): Revenue growth is expected to be 10% in FY10, vs initial expectation of 15-20%; EBITDA margins of 10-10.5%. Maintain buy with a price target of Rs 600/sh (based on 14x FY11 earnings)," says Motilal Oswal report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment.........

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com